Brief: Ngm Bio Provides Business Highlights And Reports First Quarter 2021 Financial Results
06/05/2021 22:56
May 6 (Reuters) - NGM Biopharmaceuticals Inc NGM.O :
* NGM BIO PROVIDES BUSINESS HIGHLIGHTS AND REPORTS FIRST
QUARTER
2021 FINANCIAL RESULTS
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.36
* NGM BIOPHARMACEUTICALS QTRLY RELATED PARTY REVENUE FROM
COLLABORATION WITH MERCK WAS $21.6 MILLION COMPARED TO $24.4
MILLION OR SAME PERIOD IN 2020
* Q1 EARNINGS PER SHARE VIEW $-0.42, REVENUE VIEW $22.5
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1w3MPT
Further company coverage: NGM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NGM Biopharmaceuticals
See all newsBrief: NGM Biopharmaceuticals Q4 Net Income USD -27.67 Million
Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group
NGM Biopharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
Brief: NGM Bio Announces New Clinical Data From Ongoing Trial Of Ngm707 In Advanced Solid Tumors